This is a preview of subscription content, log in via an institution to check access.
References
Pharmaceuticals and Medical Devices Agency of Japan. Revision of Precautions -- Amantadine hydrochloride. Internet Document : [1 page], 15 Sep 2015. Available from: URL: http://www.pmda.go.jp/files/000207398.pdf
Pharmaceuticals and Medical Devices Agency of Japan. Revision of Precautions -- Ipragliflozin L-proline, Luseogliflozin hydrate, and Tofogliflozin hydrate. Internet Document : [2 pages], 15 Sep 2015. Available from: URL: http://www.pmda.go.jp/files/000207399.pdf
Pharmaceuticals and Medical Devices Agency of Japan. Revision of Precautions -- Canagliflozin hydrate, Dapagliflozin propylene glycolate hydrate, and Empagliflozin. Internet Document : [3 pages], 15 Sep 2015. Available from: URL: http://www.pmda.go.jp/files/000207400.pdf
Pharmaceuticals and Medical Devices Agency of Japan. Revision of Precautions -- Fingolimod hydrochloride. Internet Document : [1 page], 15 Sep 2015. Available from: URL: http://www.pmda.go.jp/files/000207401.pdf
Pharmaceuticals and Medical Devices Agency of Japan. Revision of Precautions -- Nivolumab (genetical recombination). Internet Document : [2 pages], 15 Sep 2015. Available from: URL: http://www.pmda.go.jp/files/000207402.pdf
Pharmaceuticals and Medical Devices Agency of Japan. Revision of Precautions -- Azithromycin hydrate. Internet Document : [1 page], 15 Sep 2015. Available from: URL: http://www.pmda.go.jp/files/000207403.pdf
Pharmaceuticals and Medical Devices Agency of Japan. Revision of Precautions -- Asunaprevir, Daclatasvir hydrochloride. Internet Document : [1 page], 15 Sep 2015. Available from: URL: http://www.pmda.go.jp/files/000207404.pdf
Rights and permissions
About this article
Cite this article
Japan's PMDA revises precautions for various products. Reactions Weekly 1572, 6 (2015). https://doi.org/10.1007/s40278-015-1031-x
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-015-1031-x